Skip to main content
Clinical Trials/NCT02321670
NCT02321670CompletedNot Applicable

Scandinavian Urethroplasty Study. A Multicentre, Prospective, Randomized Study Comparing Bulbar Urethroplasty With Excision and Primary Anastomosis or With an Onlay Grafting Procedure Using Buccal Mucosa.

Oslo University Hospital8 sites in 3 countries151 target enrollmentStarted: September 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
151
Locations
8
Primary Endpoint
Penile complications

Study Overview

Brief Summary

A multicentre, prospective, randomized study comparing bulbar urethroplasty with excision and primary anastomosis or with an onlay grafting procedure using buccal mucosa.

Detailed Description

The study is a prospective, randomized study to compare two common techniques of urethroplasty used to treat bulbar urethral strictures. One technique is excision of the stricture and end-to-end anastomosis of the urethra. The other technique is an onlay grafting procedure with buccal mucosa where the corpus spongiosum is not divided. The study is designed to compare complications of sexual and penile function, and is not powered to compare the success rates of the two techniques. The primary endpoint will be degree of erectile dysfunction and penile complications. The secondary endpoint will be restricturing leading to reoperation, and other complications.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient with bulbar urethral stricture, length estimated by urethrography or endoscopy ≤ 2 cm
  • Patient is able and willing to sign informed consent
  • Patient is able and willing to complete all study requirements

Exclusion Criteria

  • Previous open urethroplasty
  • Previous hypospadia surgery
  • Previous surgery for congenital curvature or Mb Peyronie
  • Previous pelvic irradiation therapy
  • Known grave psychiatric disorder
  • Haemophilia or other clotting disorders that cause bleeding diathesis
  • Use of medication to increase erectile function, such as PDE5-inhibitors and intracavernous injections, during the study
  • Any condition or situation, which, in the investigator's opinion, puts the patient at significant risk, could confound the study results, or may interfere significantly with the patient's participation in the study

Outcomes

Primary Outcomes

Penile complications

Time Frame: up to one year

Measured by questionnaire made for this study

Degree of erectile dysfunction after surgery

Time Frame: up to one year

Measured by changes in IIEF-5

Secondary Outcomes

  • Occurrence of complications(From operation to one year)
  • Occurrence of failure within the follow up period(One year)

Investigators

Sponsor
Oslo University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ole Jacob Nilsen

Consultant, Head of section

Oslo University Hospital

Study Sites (8)

Loading locations...

Similar Trials